ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Topas and Lilly sign deal to focus on immune tolerance
pharmaceutical-technology
August 24, 2017German?biotechnology company Topas Therapeutics has signed a multi-year agreement with Eli Lilly and Company to jointly work on antigen-specific tolerance induction, with an initial focus on external antigens thought to induce inflammation and / or autoim -
Lilly pens deal for Evotec spinout’s immune tolerance drugs
fiercebiotech
August 23, 2017Eli Lilly's headquartersTopas spun out of Evotec last year, picking up €14 million ($16 million) from its parent company and other investors along the way.
Pharma Sources Insight January 2025
